Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study

Figure 1

Comparison of time on treatment between everolimus-based therapy and chemotherapy.